Search
Search Results
##search.searchResults.foundPlural##
-
Tacrolimus Associated Posterior Reversible Encephalopathy Syndrome – A Case Series and Review
3609PDF: 1518HTML: 4424CoverLetter: 189Figure1: 202 -
MOLECULAR PATHOGENESIS OF SECONDARY ACUTE PROMYELOCYTIC LEUKEMIA
2882PDF: 858HTML: 6533Untitled: 237Untitled: 200Untitled: 212Untitled: 225 -
THE PERFORMANCE OF HOMA 2 COMPARED TO DYNAMIC MARKERS OF INSULIN SECRETION AND SENSITIVITY/RESISTANCE FOR PREDICTING DYSGLYCEMIA IN TRANSFUSION-DEPENDENT Β-THALASSEMIA: THE EXPERIENCE OF A SINGLE CENTRE HOMA 2 and DYNAMIC MARKERS OF INSULIN SECRETION FOR PREDICTING DYSGLYCEMIA in TDT
101PDF: 79HTML: 14 -
THE ROLE OF SERIAL RADIOGRAPHS TO DIAGNOSE DIABETIC FOOT BONE INFECTION. Serial radiographs and diabetic foot osteomyelitis
1461PDF: 718HTML: 214 -
A rare case of superior ophthalmic vein thrombosis and thrombocytopenia following ChAdOx1 nCoV-19 vaccine against SARS-CoV-2 Ophthalmic vein thrombosis following Covid
1325PDF: 478HTML: 403 -
Successful Outcomes of Severe COVID-19 in Patient with Chronic Lymphocytic Leukemia: Diagnostic Challenges in Immunocompromised Hosts COVID-19 in cancer patients
1218PDF: 797HTML: 223 -
ADVANCES IN THE TREATMENT OF MALARIA
2876PDF: 1310HTML: 6002 -
CEREBRAL VENOUS THROMBOSIS IN THE MEDITERRANEAN AREA IN ADULTS
2287PDF: 769HTML: 1282 -
THE ROLE OF SLC22A4 IN ACUTE MYELOID LEUKEMIA
505PDF: 255HTML: 79 -
ENDOTHELIAL BIOMARKERS IN PATIENTS RECOVERED FROM COVID-19 ONE YEAR AFTER HOSPITAL DISCHARGE: A CROSS-SECTIONAL STUDY Endothelial biomarkers in COVID-19 recoverers one year after hospital discharge.
1320PDF: 737HTML: 330 -
Mantle cell lymphoma relapsing at the lymphedematous arm.
1718PDF: 702HTML: 3804 -
Thalidomide treatment for thrombocytopenia secondary to hypersplenism in children with β-thalassemia major: a case series Thalidomide treatment for thrombocytopenia
898PDF: 744HTML: 123 -
GENETIC PATHWAYS LEADING TO THERAPY-RELATED MYELOID NEOPLASMS
2605PDF: 815HTML: 5231 -
A CRITICAL HISTORY OF CHRONIC MYELOID LEUKEMIA
3270PDF: 1353HTML: 4144 -
HIV AND LYMPHOMA: FROM EPIDEMIOLOGY TO CLINICAL MANAGEMENT Guest Editors: Mario Luppi and Luca Arcaini
3566PDF: 2203HTML: 395 -
OCCULT HEPATITIS B VIRUS INFECTION AND ASSOCIATED GENOTYPES AMONG HBSAG-NEGATIVE SUBJECTS IN BURKINA FASO
4622PDF: 1209HTML: 493Figure: 233 -
Lymphomatoid Granulomatosis of Central Nervous System and Lung Driven by Epstein Barr Virus Proliferation: Successful Treatment with Rituximab
1629PDF: 894HTML: 3159Figure 5: 158Figure 4: 159Figure 3: 194Figure 1: 174Figure 2: 170 -
Is laboratory monitoring useful in DOACs management?
858PDF: 816HTML: 111 -
FLT3 Mutated Acute Myeloid Leukemia after CD19 CAR-T Cells
977PDF: 1220HTML: 115 -
DETECTION OF OCCULT GLOMERULAR DYSFUNCTION IN GLUCOSE SIX PHOSPHATE DEHYDROGENASE DEFICIENCY ANEMIA
3777PDF: 1269HTML: 1728Untitled: 174 -
NUTRITIONALLY VARIANT STREPTOCOCCI BACTEREMIA IN CANCER PATIENTS: A RETROSPECTIVE STUDY, 1999-2014
2153PDF: 1011HTML: 4079Cover Letter: 226Figure 1: 238Figure 2: 235Table 1: 207 -
THE EVOLVING ROLE OF RADIOTHERAPY IN EARLY STAGE HODGKIN’S LYMPHOMA
2256PDF: 957HTML: 6795Figure 1: 177 -
Treating relapsed/refractory acute myeloid leukemia with chidamide, fludarabine, cytarabine and granulocyte-colony stimulating factor with subsequent bridging to myeloablative allogeneic hematopoietic stem cell transplantation Treating relapsed/refractory acute myeloid leukemia with chidamide, fludarabine, cytarabine and G-CSF
1791PDF: 584HTML: 291 -
CENTRAL NERVOUS SYSTEM INVOLVEMENT IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA: DIAGNOSTIC TOOLS, PROPHYLAXIS AND THERAPY
4148PDF: 1955HTML: 5330Table 1: 201 -
Acquired Hemophilia A successfully treated with rituximab
2009PDF: 1156HTML: 1459Figure 1: 183







